ArticleCureus2026
Evaluating the Efficacy of EcoSAFE: A Superoxidized Solution With HOCl at Neutral pH for Infection Control.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Hospital-acquired infections (HAIs) pose a major challenge to healthcare systems, increasing patient morbidity, mortality, and costs. Contaminated air and surfaces in hospitals serve as key sources of infection transmission. Developing safe, reliable, and efficient disinfection methods is essential to minimizing microbial contamination in these environments. Objective This study assessed the effectiveness of EcoSAFE superoxidized solution containing hypochlorous acid (HOCl) at neutral pH in reducing microbial contamination and improving infection control in hospital settings. This study aimed to assess the effectiveness of EcoSAFE in preventing and controlling infections in high and moderate-risk areas within hospital settings. The results highlight EcoSAFE's serve as a safer, practical and more efficient alternative to conventional disinfectants for infection control. Therefore, EcoSAFE will be of great interest in the development of continuous room disinfection methods, surface disinfectants and equipment cleaning in hospitals. Methods The evaluation was carried out at the Rajan Babu Institute of Pulmonary Medicine and Tuberculosis Hospital (RBIPMTH), New Delhi. EcoSAFE was applied for routine disinfection of operation theaters and hospital surfaces by both spraying and fumigation. Air and surface samples were collected before and after treatment, and microbial counts were determined by measuring colony-forming units (CFUs) to assess the reduction in bacterial and fungal load. A total of 1,056 surface swab samples (528 pre- and 528 post-disinfection) and 960 air-exposed plates were analyzed. Microbial load was assessed before and after treatment by quantifying colony-forming units (CFUs). Results Following the EcoSAFE application, there was a 100% reduction in growth on all 528 post‑fumigation surface swabs and up to 100% reduction in airborne colony counts in both high‑ and moderate‑risk areas. The solution demonstrated rapid antimicrobial action, achieving significant reduction within minutes of contact. Disinfection did not require the closure of operation theaters, and no odor, irritation, or post-cleaning residues were noted. The product was convenient to handle, non-corrosive, and entirely safe near hospital personnel and patients; no personal protective equipment (PPE) was needed during use. Conclusion EcoSAFE proved to be an effective, safe, and easy-to-use disinfectant for healthcare environments. Its quick action, neutral pH, and absence of chemical residues make it a practical option for routine use. Adoption of EcoSAFE in hospital infection control programs may help reduce microbial contamination and contribute to the prevention of HAIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.